Trial
NCT01478321
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
—
Condition
Adult Anaplastic Astrocytoma
Intervention
Temozolomide
Why stopped
Slow accrual to some cohorts
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-12